Home/Filings/4/0001209191-20-053919
4//SEC Filing

DUGAN MICHAEL C 4

Accession 0001209191-20-053919

CIK 0001044378other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 8:25 PM ET

Size

5.3 KB

Accession

0001209191-20-053919

Insider Transaction Report

Form 4
Period: 2020-10-01
DUGAN MICHAEL C
Chief Med Off & Med. Director
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-10-01+69,00069,000 total
    Exercise: $4.50Exp: 2030-09-30Common Stock (69,000 underlying)
Footnotes (1)
  • [F1]1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 10/1/2020 until fully vested on 10/1/2023.

Issuer

BIOCEPT INC

CIK 0001044378

Entity typeother

Related Parties

1
  • filerCIK 0001239105

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 8:25 PM ET
Size
5.3 KB